MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Conditions
Low Grade Glioma · High Grade Glioma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Children's National Hospital, Washington D.C., District of Columbia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study leads
Ashley Plant-Fox, MD
Principal Investigator
Ann & Robert H Lurie Children's Hospital of Chicago